EPIDEMIOLOGICAL investigations have demonstrated individuals infected with
Helicobacter pylori to be at an increased risk for cancer of the gastric body and antrum.
1,2 In response to these findings, the International Agency for Research on Cancer classified
H pylori as a group 1 carcinogen in humans, raising the question whether population-based screening should be undertaken.
3 To date, no controlled trials have demonstrated that
H pylori eradication alters the risk of gastric cancer. Moreover, results from prospective studies that directly quantify the impact of
H pylori eradication on the risk of cancer on low-risk individuals are decades away.